Milky Mist IPO: Rs 1,553 Cr Raise, Price Band Rs 133-140
By ThePip Desk
Milky Mist Dairy Food’s IPO opens Aug 11, aiming to raise Rs 1,553 Cr. Explore price band Rs 133-140, lot size, and fund utilization.
Milky Mist Dairy Food’s Initial Public Offering launched on August 11, 2026, aiming to secure Rs 1,553 crore from the market. The subscription window for the dairy products company is set to close on August 13, 2026.
Key IPO Details
- The price band for the offering is between Rs 133 and Rs 140 per share.
- Retail investors must bid for a minimum lot size of 107 shares.
- This translates to a minimum investment of Rs 14,980 at the upper end of the price band.
- The IPO includes a fresh issuance of 10.20 crore shares, valued at Rs 1,428 crore.
- An offer for sale (OFS) component of 0.89 crore shares will raise Rs 125 crore.
The company plans to list its shares on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). Allotment is expected by August 14, with a tentative listing date of August 18.
Fund Utilization Strategy
A significant portion of the capital raised is earmarked for strategic initiatives to enhance the company’s financial health and operational capacity.
- Approximately Rs 496.86 crore will be used for debt reduction.
- Rs 469.24 crore is allocated for capital expenditure, specifically for expanding and modernizing its Perundurai manufacturing facility.
- Around Rs 155.31 crore will be invested in visi coolers, ice cream freezers, and chocolate coolers.
- The remaining funds are designated for general corporate purposes.
Company Profile and Market Outlook
Founded in 2014, Milky Mist Dairy Food has established a strong presence in the value-added dairy sector. Its extensive product portfolio includes cheese, paneer, butter, curd, ghee, and ice cream, marketed under brands like Milky Mist, SmartChef, and Capella.
The Grey Market Premium (GMP) on August 11 stood at Rs 20.50, suggesting an estimated listing price of approximately Rs 160.50. This indicates a potential gain of about 14.6% over the issue price, though investors are cautioned against relying solely on GMP for investment decisions.